Cytogenix Inc. (CYGX/CYGX.OB) Wrap Up:

CytoGenix, Inc., a biopharmaceutical company, focuses on the development and commercialization of its technology for identifying and silencing disease causing genes and expressing proteins for applications, such as vaccines and isolating novel nucleic acid-based anti-microbial compounds. Its technologies include gene silencing techniques applicable to genes from pathogenic organisms or selected genes from a host to prevent the expression of harmful proteins, thereby preventing, or ameliorating disease; a cell free process to produce DNA for use in its own products, as well as for sale to other biopharmaceutical or life science companies; and a methodology to isolate and characterize DNA-base...